tiprankstipranks
Trending News
More News >
Psyence Group Inc. (TSE:PSYG)
:PSYG
Canadian Market

Psyence Group (PSYG) Price & Analysis

Compare
5 Followers

PSYG Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

3.88%96.12%
Mutual Funds
― Other Institutional Investors
96.12% Public Companies and
Individual Investors

PSYG FAQ

What was Psyence Group Inc.’s price range in the past 12 months?
Psyence Group Inc. lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.
    What is Psyence Group Inc.’s market cap?
    Psyence Group Inc.’s market cap is C$2.11M.
      When is Psyence Group Inc.’s upcoming earnings report date?
      Psyence Group Inc.’s upcoming earnings report date is Jul 08, 2025 which is in 73 days.
        How were Psyence Group Inc.’s earnings last quarter?
        Psyence Group Inc. released its earnings results on Feb 28, 2025. The company reported -C$0.06 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.06.
          Is Psyence Group Inc. overvalued?
          According to Wall Street analysts Psyence Group Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Psyence Group Inc. pay dividends?
            Psyence Group Inc. does not currently pay dividends.
            What is Psyence Group Inc.’s EPS estimate?
            Psyence Group Inc.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Psyence Group Inc. have?
            Psyence Group Inc. has 9,387,695 shares outstanding.
              What happened to Psyence Group Inc.’s price movement after its last earnings report?
              Psyence Group Inc. reported an EPS of -C$0.06 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Psyence Group Inc.?
                Currently, no hedge funds are holding shares in TSE:PSYG
                ---

                Company Description

                Psyence Group Inc.

                Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Numinus Wellness
                Revive Therapeutics
                Cybin
                HAVN Life Sciences
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis